Trans-siduron

Catalog No.: 
ACAEQG129
CAS No.: 
19123-21-8
Molecular Formula: 
C14H20N2O
Molecular Weight: 
232.33
Trans-siduron structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$268.00InquiryInquiry
250mg95%$446.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTrans-siduron
IUPAC Name1-((1R,2R)-2-methylcyclohexyl)-3-phenylurea
MDL No.MFCD01863777
Molecular FormulaC14H20N2O
Molecular Weight232.33
SMILESO=C(N[C@H]1[C@@H](CCCC1)C)NC2=CC=CC=C2
InChI KeyJXVIIQLNUPXOII-DGCLKSJQSA-N
SynonymTRANS-SIDURON PESTANAL 250 MG;1-[(1S,2S)-2-methylcyclohexyl]-3-phenylurea;rel-N-[(1R,2R)-2-Methylcyclohexyl]-N'-phenylurea;Urea, N-[(1R,2R)-2-methylcyclohexyl]-N'-phenyl-, rel-;Aldicarb Impurity 4 (Butocarboxim)
CAS No.19123-21-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAEQG129 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFLJZ857 route compound structure diagram
    ACFLJZ85739558-31-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEQG129 route product structure diagram
    ACAEQG12919123-21-8
Inquiry

2. ACAEQG129 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEQG129 route product structure diagram
    ACAEQG12919123-21-8
Inquiry

3. ACAEQG129 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEQG129 route product structure diagram
    ACAEQG12919123-21-8
Inquiry

Comments (0)